AIMMUNE THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 44770000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2019-01-01 – 2019-09-30
Statuscurrent
EntityAIMMUNE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-19-041059 · Open the official SEC filing →
Retrieved: 2026-08-19T16:46:43.812497+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001631650/cashflow-financing/2019-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b7a61a0d-e4ea-43e2-9f34-b516be04486c

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies